SAN JOSE, Calif., Aug. 14 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices forthe minimally invasive treatment of venous reflux disease, is enjoying ...

The VeClose study was primarily performed in order to compare the efficiency and safety of Covidien’s existing ClosureFast catheter with the new VenaSeal closure system. Both of these cater to ...

"Our study found the ratio of efficacy to side effects of the VNUS ClosureFAST catheter to be superior to any previous endovenous ablation device," said Dr. Proebstle. "In 223 cases where the ...

Covidien (Mansfield, Massachusetts) reported the five-year results of its ClosureFast long-term European multi-center study in patients with chronic venous insufficiency (CVI). This study evaluates ...

Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency MANSFIELD, Mass.-- Covidien, a leading global provider of ...

Covidien Announces Five-Year Results from the ClosureFast™ Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease Study Demonstrates Long-Term Durability of the ClosureFast™ ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast ® ...

DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over ...

Covidien reports its ClosureFast device has proven itself in a 5-year study--courtesy of Covidien Covidien ($COV) has wrapped up a 5-year study of its ClosureFast ...

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal™ closure ...

September 26, 2006 -- The US Food and Drug Administration (FDA) has granted a clinical laboratory improvement amendment waiver for a portable lead test, thereby improving its availability and access, ...